Eptinezumab May Significantly Reduce Migraine-Related Burden in Chronic Migraine
Eptinezumab treatment for chronic migraine was associated with significant reduction in migraine-related burden on work, home, and social functioning.
All articles by Amit Akirov, MD
Promising Results for Lacosamide in the Treatment of Chronic Migraine
Lacosamide, an anti-epileptic drug that inhibits phosphorylation of collapsing response mediator protein 2 and blocks the release of calcitonin gene-related peptide in the trigeminal system, may be effective in the treatment of chronic migraine.
Estradiol May Protect Against Cognitive Impairment Mediated by Visceral Adiposity
Estradiol has anti-inflammatory properties and can strengthen the hypothalamic-pituitary-adrenal axis, which may oppose the effects of visceral adiposity.
High Adolescent Fasting Plasma Glucose May Have an Impact on Brain Health in Midlife
Mean fasting plasma glucose in the high-normal range during early adolescence may be associated with poorer brain health in midlife.
Next post in Neurocognitive Disorders
